Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

IFOSFAMIDE/MESNA KIT

IFOSFAMIDE; MESNA

Standard Dose
3GM/60ML;1GM/10ML (50MG/ML;100MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview IFOSFAMIDE/MESNA KIT is listed in Drugs@FDA under application 075874 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient IFOSFAMIDE; MESNA Form and strength INJECTABLE;INTRAVENOUS - 3GM/60ML;1GM/10ML (50MG/ML;100MG/ML) Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2015-05-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview IFOSFAMIDE/MESNA KIT is listed in Drugs@FDA under application 075874 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient IFOSFAMIDE; MESNA Form and strength INJECTABLE;INTRAVENOUS - 3GM/60ML;1GM/10ML (50MG/ML;100MG/ML) Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2015-05-26 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.